Vor Biopharma competitorsClear all

Vor Biopharma's top competitors include Actuate Therapeutics, Celgene and Arvinas.
Vor Biopharma
Vor Biopharma
Vor Biopharma is a biopharmaceutical company developing novel therapies with potential for treating cancer.
Actuate Therapeutics
Actuate Therapeutics
Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic agents for patients with cancer or inflammatory diseases.
Celgene
Celgene
Celgene Corporation is a biopharmaceutical company.
Arvinas
Arvinas
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
Founding Date
Founding Date
2016
Founding Date
2015
Founding Date
1986
Founding Date
N/A
Type
Type
Private
Type
Private
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Boston, US HQ
Locations
Fort Worth, US HQ
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
New Haven, US HQ
Employees
Employees
5
Employees
N/A
Employees
N/A
Employees
10311% increase
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
26.6 k
Twitter followers
1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
3
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
10.6
Average likes per tweet (last 30 days)
2.7
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
394956
Alexa Website Rank
523488
Alexa Website Rank
315342
Alexa Website Rank
396803

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$15.3b (FY, 2018)
Revenue (est.)
$14.3m (FY, 2018)
Net income
Net income
N/A
Net income
N/A
Net income
$4b (FY, 2018)
Net income
($41.5m) (FY, 2018)

Funding

Latest funding round
Latest funding round
$ 42m (10 months ago)
Latest funding round
$ 6.5m (27 days ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 42m
Total funding raised
$ 31.2m
Total funding raised
N/A
Total funding raised
$ 111.6m
For sources of this data, please see the company profile

View company profiles

Actuate Therapeutics
HQ
Fort Worth, US

Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic agents for patients with cancer or inflammatory diseases.

View company
Celgene
HQ
Summit, US

Celgene Corporation is a biopharmaceutical company.

View company
Arvinas
HQ
New Haven, US
Employees
103↑ 11% increase

Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.

View company